Vol. 58 No. 3 (2019): Acta Oncologica

Articles

• Chondrosarcoma in Norway 1990–2013; an epidemiological and prognostic observational study of a complete national cohort

  Joachim Thorkildsen, Ingeborg Taksdal, Bodil Bjerkehagen, Hans Kristian Haugland, Tom Børge Johannesen, Trond Viset, Ole-Jacob Norum, Øyvind Bruland, Olga Zaikova

  273-282

  Published: 2023-10-26

  • PDF

• Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy

  He J. Zhu, Romaine C. Nichols, Randal H. Henderson, Christopher G. Morris, Stella Flampouri, Dat C. Pham, Christopher L. Klassen, Vandana Seeram, James D. Cury, Lisa Jones, Lisa McGee, Bradford S. Hoppe

  313-319

  Published: 2019-03-04

  • PDF

• The potential diagnostic and prognostic role of extracellular vesicles in glioma: current status and future perspectives

  Zulfikar Azam, Véronique Quillien, Gang Wang, Shing-Shun Tony To

  353-362

  Published: 2019-03-04

  • PDF

• Salivary gland carcinomas with unusual presentations

  Carl Frederik Haugaard, Tina Klitmøller Agander, Giedrius Lelkaitis, Kim Francis Andersen, Simon Andreasen, Irene Wessel

  382-384

  Published: 2019-03-04

  • PDF

• Women with cervical cancer precursor lesions: a high-risk group for human papillomavirus (HPV)-related oropharyngeal cancer?

  Louise T. Thomsen, Susanne K. Kjær

  265-266

  Published: 2019-03-04

  • PDF

• Diagnostic spectrum and time intervals in Sweden’s first diagnostic center for patients with nonspecific symptoms of cancer

  Emelie Stenman, Karolina Palmér, Stefan Rydén, Charlotta Sävblom, Inga Svensson, Carsten Rose, Jianguang Ji, Mef Nilbert, Jan Sundquist

  296-305

  Published: 2019-03-04

  • PDF

• Improved treatment of glioblastoma – changes in survival over two decades at a single regional Centre

  Maria Eriksson, Jenna Kahari, Amanda Vestman, Mattias Hallmans, Mikael Johansson, A. Tommy Bergenheim, Maria Sandström

  334-341

  Published: 2019-03-04

  • PDF

• Neutrophil lymphocyte ratio is significantly associated with complete response to chemoradiation in locally advanced cervical cancer

  Aparna Gangopadhyay

  377-379

  Published: 2019-03-04

  • PDF

• On the relation between improved loco-regional control and disease-free survival in head-and-neck cancer

  Katrin Håkansson, Jacob H. Rasmussen, Søren M. Bentzen, Jeppe Friborg, Lena Specht, Ivan R. Vogelius

  390-392

  Published: 2019-03-04

  • PDF

• Gastric cancer trends in Estonia 1995–2014 by age, subsite, morphology and stage

  Mari-Leen Pärn, Kaire Innos, Aleksei Baburin, Raul-Allan Kiivet, Jana Jaal

  283-289

  Published: 2019-03-04

  • PDF

• Pattern of endocrine treatment for epithelial ovarian cancer in the Southeast medical region of Sweden: a population-based study

  Ebba Bagge, Ulrica Beiron, Susanne Malander, Per Rosenberg, Elisabeth Åvall-Lundqvist

  320-325

  Published: 2019-03-04

  • PDF

• Evaluation of tumor-infiltrating lymphocytes and association with prognosis in BRCA-mutated breast cancer

  I. M. H. Sønderstrup, M. B. Jensen, B. Ejlertsen, J. O. Eriksen, A. M. Gerdes, T. A. Kruse, M. J. Larsen, M. Thomassen, A. V. Laenkholm

  Published: 2023-10-27

  • PDF

• Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer

  Lars Ottestad, Line Fronth, Sajitha Rajendiran, Liv Hege Aksnes, Hans Petter Eikesdal, Egil Støre Blix, Marianne Ewertz

  385-387 |

  Published: 2019-03-04

  • PDF

• Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study

  Julie T. Christensen, Christian Grønhøj, Martin Zamani, Julie Brask, Henrik Lajer, Christian von Buchwald

  267-272 |

  Published: 2019-03-04

  • PDF

• Metastatic papillary renal cell carcinoma in the era of targeted therapy – a retrospective study from three European academic centres

  Maria Stenman, Michael Staehler, Bernadett Szabados, Per Sandström, Anna Laurell, Magnus Lindskog, Ulrika Harmenberg

  306-312

  Published: 2019-03-04

  • PDF

• The role of biomarkers in endometrial cancer and hyperplasia: a literature review

  Suzanna Hutt, Anil Tailor, Agnieszka Michael, Simon Butler-Manuel, Jayanta Chatterjee

  342-352

  Published: 2019-03-04

• The efficacy of platinum-based chemotherapy for immune checkpoint inhibitor-resistant advanced melanoma

  Takuya Maeda, Koji Yoshino, Kojiro Nagai, Satoe Oaku, Megumi Kato, Azusa Hiura, Hiroo Hata

  379-381

  Published: 2019-03-04

  • PDF

• Correction

  393

  Published: 2019-03-18

  • PDF

• Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden

  C. Kilander, J. Lagergren, P. Konings, O. Sadr-Azodi, N. Brusselaers

  290-295

  Published: 2019-03-04

  • PDF

• Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer

  Johannes J. M. Kwakman, Rob C. M. van Kruijsdijk, Sjoerd G. Elias, Matthew T. Seymour, Angela M. Meade, Frank L. J. Visseren, Cornelis J. A. Punt, Miriam Koopman

  326-333

  Published: 2019-03-04

  • PDF

• The prognostic role of inflammation-scores on overall survival in lung cancer patients

  Birgitte Sandfeld-Paulsen, Peter Meldgaard, Boe S. Sorensen, Akmal Safwat, Ninna Aggerholm-Pedersen

  371-376

  Published: 2019-03-04

  • PDF

• Reactive capillary hemangiomas induced by camrelizumab (SHR-1210), an anti-PD-1 agent

  Yan Teng, Ruifeng Guo, Jianfang Sun, Yi Liu

  388-389

  Published: 2019-03-04

  • PDF